Sitagliptin: a viewpoint by Mark S. Kipnes

Drugs. 2007;67(4):598-9. doi: 10.2165/00003495-200767040-00009.
No abstract available

MeSH terms

  • Adenosine Deaminase Inhibitors*
  • Animals
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl Peptidase 4
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Glycoproteins / antagonists & inhibitors*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Pyrazines / therapeutic use*
  • Sitagliptin Phosphate
  • Triazoles / therapeutic use*

Substances

  • Adenosine Deaminase Inhibitors
  • Dipeptidyl-Peptidase IV Inhibitors
  • Glycoproteins
  • Hypoglycemic Agents
  • Pyrazines
  • Triazoles
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4
  • Sitagliptin Phosphate